This poll is based on the session titled “State of Depression” at Psych Congress 2022 by Charles DeBattista, MD, DMH, professor of psychiatry and behavioral sciences and director of the Depression Research...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
The use of social media in medicine is a growing trend worldwide, as it is quick and easy to connect with peers and share knowledge. How do you typically use social media?
Rheumatoid arthritis (RA) treatment often consists of pharmacologic and nonpharmacologic interventions. Which nonpharmacologic intervention has been most helpful to your patients with RA? Let us know by...
Because glucocorticoid-induced osteoporosis (GIOP) is becoming a more common issue in rheumatology practice, it is important for rheumatologists to understand anabolic and antiresorptive agents for treating...
Sublingual allergen immunotherapy has been examined as an alternative treatment option in recent years for individuals with allergic asthma. Is this a treatment option you utilize when managing patients...
Chronic fatigue syndrome, or myalgic encephalomyelitis, is an organic disease of unknown origin. It can affect various parts of the body as well as patients' sleep. Do you think neurologists should be the...
The USPSTF released a recommendation statement regarding the benefit of screening children and adolescents for type 2 diabetes. Take our poll to let us know what you think!
